Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 9409 - 9416 of 11617 results
2014 IPO Statistics: IPO Boom?
January 21, 2015| Blog| Viewpoint
"Appraisal Arbitrage" Receives Boost from Delaware Court of Chancery
January 21, 2015| Blog| Viewpoint
Cybersecurity and Privacy in State of the Union Address
January 21, 2015| Blog| Viewpoint
Proposition 65 May Mean More Than Warning Signs and Lawsuits
January 20, 2015| Blog| Viewpoint
Washington Outlook for 2015
January 20, 2015| News
Privacy Monday - January 19, 2015: New Additions to Mintz's Privacy & Security Group
January 19, 2015| Blog| Viewpoint
Who is “Disabled” under ABLE?
January 19, 2015| Blog| Viewpoint
New Funding for Energy Innovation: D.O.E. Announces $125 Million for Transformational Energy Projects
January 16, 2015| Blog| Viewpoint
News & Press Releases
Mintz Announces New Members
December 20, 2024
Mintz announces the election of eight attorneys to Members, effective January 1, 2025. The newly promoted Members join the ranks of the firm’s growing membership, including six new lateral Members who joined the firm in 2024.
Mintz represented the US Department of Energy (DoE) Loan Programs Office (LPO) in the closing of a $1.45 billion loan guarantee to Hanwha Q Cells Georgia, Inc. (QCells), a leading North American crystalline silicon solar manufacturer.
Dealmaking Dormant No More
December 17, 2024
International Chair of Life Sciences Cheryl Reicin recently participated in a Q&A with Pharmaceutical Executive in which she discusses the ongoing effects of the pandemic on dealmaking trends in the pharmaceutical industry. Cheryl specifically mentions how M&A activity began to rise again in 2024 after slowing in 2023, and that she expects acquisitions to continue picking up in 2025.